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ABSTRACT
ObjectiveTodescribethecharacteristicsatenrolmentand
outcomes of doctors in a substance dependence
monitoring programme in Canada.
Design Prospective descriptive study.
Setting Provincial physician health programme, Canada.
Participants All 100 doctors consecutively admitted to a
substance dependence monitoring programme and
followed until completion of monitoring or on leaving the
programme.
Main outcome measure Relapse during long term
monitoring for five years.
Results Ninety per cent of the doctors enrolled on the
programme were men, 66% were married or living with a
partner, 44% had had previous treatment for substance
dependence, and 36% had had previous psychiatric
treatment. Smokers were over-represented compared
with the general population of US doctors (38% v 5%).
During the monitoring period 71% of participants had no
known relapse. An additional 14% went on to complete
the programme, after some form of relapse. In total, 85%
of the doctors successfully completed the programme.
Conclusion In this cohort of doctors enrolled on the
Ontario Physician Health Program for substance
dependence, most were men who were dependent on
alcohol or opioids. Smokers were over-represented
compared with the general population of US doctors.
Eighty five per cent successfully completed the
programme.
INTRODUCTION
Programmes to help doctors who are dependent on
substances such asdrugs and alcohol exist in every US
state
1 and every Canadian province,
2 in collaboration
with medical associations or regulatory bodies. The
British Medical Association also has developed a peer
supportprogramme.
3Descriptionsofparticipantswith
drugrelatedproblemsinphysicianhealthprogrammes
consistently show that alcohol is the most common
drug of choice, followed by opioids, and that multiple
drug use is common.
4-7 Female doctors are generally
under-represented as participants.
6-8 Among these
doctors, long term recovery rates are higher than
those for substance use disorders in the general
population, often exceeding 85%.
48-10
In Canada the Ontario Physician Health Program is
among the largest of such programmes and, by 2002,
hadenrolled100doctorsformonitoringrecoveryfrom
substance dependence. Recovering doctors who
choose monitoring are enrolled by a case manager
fromtheprogrammeaftertheyhavebeendiagnosedas
dependent on substances, successfully treated, and
establishedinearlystableremission.Contractrequire-
ments for monitoring include visits to an addiction
medicine doctor, visits to a family doctor for routine
health needs, attendance at facilitated health profes-
sional support groups, attendance at mutual support
groups in the community, monitoring in the work-
place, and random screening of urine for alcohol and
drugsofmisuse.Theusualagreementformonitoringis
five years of continuing progress in recovery. Con-
tingencies built into the monitoring agreement can
resultindetailsofthecasebeingreportedtotheCollege
of Physicians and Surgeons of Ontario, the regulatory
body, when aspects of the contract are breached.
Bytheendof2007allofthefirst100doctorsenrolled
ontheOntarioPhysicianHealthProgramformonitor-
ingofsubstancedependencehadcompletedcontracts.
We describe these doctors and their outcomes.
METHODS
Participants were the first 100 doctors enrolled in the
Ontario Physician Health Program for monitoring of
substance dependence after the formation of the
programme in 1995. All were diagnosed as dependent
onsubstancesaccordingtocriteriaoftheDiagnosticand
StatisticalManualofMentalDisorders,fourthedition,and
treatedforsubstancedependence,usuallyinaresiden-
tialabstinencebasedprogrammefor4-6weeks,before
entering the monitoring programme.
Intake measure and outcome measure (relapse)
On entering the monitoring programme, the doctors
completed a clinical intake questionnaire detailing
personalcharacteristics, historyofsubstancemisusein
the family, professional education and practice,
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psychiatric history, and experience of physical and
emotional abuse.
While being monitored by the physician health
programme, any use of alcohol or an illicit drug or use
of any psychoactive drug not prescribed by a
participant’s doctor was considered to be relapse.
Relapse ranges from single use to full resumption of
dependence on substance use. After brief relapse,
participants may continue the monitoring programme
to successful completion; more serious relapse may
lead to the doctor having to restart the programme
under a new contract or leaving the programme.
Data analysis
The data were analysed using SPSS version 15.0. We
summarised the characteristics of participants using
frequencies for categorical variables and means and
standard deviations for continuous variables.
RESULTS
The table shows the personal characteristics of the
participants, details of their practices, and drug and
treatment histories on entry to the monitoring pro-
gramme. In total, 90% of participants were men; two
thirds(66%)weremarriedorlivingwithapartner.The
mean (SD) age at enrolment was 45 (11) years, with a
mean (SD) years experience of medical practice of 16
(11)years.Almostahalf(48%)wereingeneralpractice
orfamilypractice.Mostpractisedpatientcareinsingle
or group practices, and most practised in urban areas,
communitiesof100000ormore.Thesecharacteristics
were generally similar to the population of Ontario
doctors(Member Services Department,Ontario Med-
ical Association). The licences of two thirds (69%) of
participants were unaffected at the time of enrolment;
the remainder (31%) were suspended or restricted
(mostly to prevent the prescribing of narcotics). Two
thirds of participants enrolled to satisfy a requirement
of the College of Physicians and Surgeons of Ontario.
Half of the participants (51%) used alcohol as their
primary drug of choice, one third opioids (37%), and
the remainder (36%) other drugs such as benzodiaze-
pines, stimulants, or illicit drugs such as cannabis or
cocaine. Nearly half (44%) had received drug related
t r e a t m e n ta ts o m et i m eb e f o r et h em o s tr e c e n t
treatment. More than a third (38%) were current
smokers, higher than the current rate of smoking
among the general population of US doctors, which is
about 5%.
11 Thirty six per cent of the participants had
had psychiatric treatment in the previous five years.
Morethanhalf(60%)reportedeverexperiencingsome
form of physical or emotional abuse.
During the monitoring period 71% of participants
had no known relapse. An additional 14% went on to
complete the monitoring programme after some form
of relapse. In total, 85% of the doctors successfully
completed the programme.
DISCUSSION
Doctors who entered the Ontario Physician Health
Program for substance dependence were typically
middle aged, married men dependent on alcohol or
opioids. Overall, 85% of the participants successfully
completed the programme.
Thestrengthofourstudyisthattheparticipantswere
100 doctors consecutively admitted for monitoring of
Participants’personalcharacteristicsandhistoryofdruguseandtreatmentatenrolmentinthe
Ontario Physician Health Program
Variable No (%)
No of participants (n=100)
Men 90 (90)
Women 10 (10)
Marital status (n=100):
Married or living with a partner 66 (66)
Single 34 (34)
Specialty (n=92):
General practice or family practice 47 (51)
Specialist 45 (49)
Practice setting (n=86):
Single practice 35 (41)
Group practice 20 (23)
Other 31 (36)
Practice community size (n=94):
<5000 3 (3)
5000-24 999 7 (7)
25 000-99 999 18 (19)
100 000-500 000 39 (41)
>500 000 27 (29)
Status of medical licence (n=96):
Unaffected 66 (69)
Restricted or suspended 30 (31)
Involved with licensing body* at enrolment (n=99):
Yes 65 (66)
No 34 (34)
Primary drug of choice (n=95):
Alcohol 48 (51)
Opioids 35 (37)
Other 12 (13)
Previous treatment for drug related problem (n=97):
Yes 43 (44)
No 54 (56)
Current tobacco smoker (n=93):
Yes 35 (38)
No 58 (62)
Previous psychiatric treatment (past five years) (n=100):
Yes 36 (36)
No 64 (64)
Ever experienced physical or emotional abuse (n=96):
Yes 58 (60)
No 38 (40)
Ever been sued for malpractice (n=96):
Yes 15 (16)
No 81 (84)
Mean (SD) age at enrolment (n=100) 45.4 (10.5)
Mean (SD) years in practice (n=94) 16.2 (10.8)
*College of Physicians and Surgeons of Ontario was aware of participant’s contract with physician health
programme.
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gramme, without selection. Results were accumulated
over 10 years, the time taken for 100 doctors to
complete at least five years of monitoring.
One possible weakness of the study is that the
characteristics of doctors entering the programme
could change over this time span. Measures on the
intake questionnaire were by self report and subject to
the limitations of that method. Possibly we failed to
identify some relapses, leading to misclassification of
outcomes. The relatively small number of participants
prevented us from studying the relation between
characteristics ofthe participantsatintakeand relapse.
This profile of the personal characteristics of the
participants and their practices is typical of other
reports of participants in physician health pro-
grammes, where women are under-represented.
4-8
The high rate of smoking among the participants
compared with the general population of US doctors
(38% v 5%) and the high success rate is comparable to
that of other North American physician health
programmes that report outcomes for monitoring
substance dependence.
48-10
Doctors entering a substance dependence monitor-
ing programme are more likely to be men and to be
smokersthanotherdoctors.Theyareusuallyknownto
the licensing body. Their primary drugs of choice are
alcohol or opioids. A structured monitoring pro-
gramme after abstinence based primary treatment for
these substance dependent doctors, with regulatory
contingencies for lack of adherence, can produce
successful results. Further research is needed to
examine the relation of the characteristics of the
doctors and components of the programme to relapse,
so that monitoring can be tailoredto the specific needs
of participants.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Studies have shown a high rate of successful outcomes in doctors enrolled in monitoring
programmes for substance dependence
WHAT THIS STUDY ADDS
In a sample of 100 doctors consecutively admitted to a physician health programme, most
were men and the drugs of dependence were alcohol or opioids
Afterabstinencebasedresidentialtreatment,85% ofthedoctors successfully completedthe
comprehensive programme of monitoring with contractual contingencies
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